The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?
出版年份 2021 全文链接
标题
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 5, Pages 996
出版商
MDPI AG
发表日期
2021-03-02
DOI
10.3390/jcm10050996
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism
- (2020) Megan M. Weivoda et al. Nature Communications
- Effects of age and sex on osteocalcin and bone-specific alkaline phosphatase—reference intervals and confounders for two bone formation markers
- (2020) Sarah Seberg Diemar et al. Archives of Osteoporosis
- RANKL induces beige adipocyte differentiation in preadipocytes
- (2020) Flávia Sayuri Matsuo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension
- (2020) Serge Ferrari et al. BONE
- The Interplay Between Bone and Glucose Metabolism
- (2020) Cristiana Cipriani et al. Frontiers in Endocrinology
- Bone turnover markers do not predict fracture risk in type 2 diabetes
- (2020) Nicola Napoli et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Regulation, Microarchitecture, And Advanced Glycation End‐Products In The Bone Of Elderly Women With Type 2 Diabetes
- (2020) Alessandra Piccoli et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
- (2020) Jonas Bovijn et al. Science Translational Medicine
- Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle
- (2020) Toshihisa Komori INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Osteocalcin—A Versatile Bone-Derived Hormone
- (2019) Sarah C. Moser et al. Frontiers in Endocrinology
- Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol
- (2019) Yihui Liu et al. BMJ Open
- Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials
- (2019) Mary L Bouxsein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism
- (2019) Min Yang et al. FASEB JOURNAL
- RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
- (2019) Nicolas Bonnet et al. JOURNAL OF CLINICAL INVESTIGATION
- A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls
- (2019) Zhongyu Liu et al. BMC MUSCULOSKELETAL DISORDERS
- Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
- (2019) Donna M. Pacicca et al. Scientific Reports
- Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies
- (2018) Bente L. Langdahl et al. BONE
- Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial
- (2018) Nicola Napoli et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
- (2018) Nicola Napoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model
- (2018) Young-Seok Lee et al. Spine Journal
- Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)
- (2018) Anna Wędrychowicz et al. BONE
- Alendronate improves fasting plasma glucose and insulin sensitivity and decreases insulin resistance in prediabetic osteopenic postmenopausal women: a randomized triple-blind clinical trial
- (2018) Maryam Karimi Fard et al. Journal of Diabetes Investigation
- A novel role of bone morphogenetic protein 6 (BMP6) in glucose homeostasis
- (2018) Martina Pauk et al. ACTA DIABETOLOGICA
- Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men
- (2017) Limin Tian et al. MEDICINE
- Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
- (2017) Soohyun P. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum Osteocalcin and Testosterone Concentrations in Adult Males with or without Primary Osteoporosis: A Meta-Analysis
- (2017) Zhong-Yu Liu et al. Biomed Research International
- Teriparatide in patients with osteoporosis and type 2 diabetes
- (2016) Ann V. Schwartz et al. BONE
- Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis
- (2016) Ozgen Celer et al. CLINICAL ENDOCRINOLOGY
- Decreased circulating BMP-9 levels in patients with Type 2 diabetes is a signature of insulin resistance
- (2016) Yong Luo et al. CLINICAL SCIENCE
- Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism
- (2016) Lovorka Grgurevic et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Zoledronic Acid Improves Bone Quality in the Streptozotocin-Induced Diabetes Rat through Affecting the Expression of the Osteoblast-Regulating Transcription Factors
- (2016) M. Cui et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus
- (2016) Maria Felicia Faienza et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial
- (2015) Patrizia D'Amelio et al. BONE
- Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
- (2015) Daisuke Inoue et al. CALCIFIED TISSUE INTERNATIONAL
- Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis
- (2015) Antonino Lasco et al. CALCIFIED TISSUE INTERNATIONAL
- Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway
- (2015) Nagesha Guthalu Kondegowda et al. Cell Metabolism
- Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence
- (2015) Setor Kwadzo Kunutsor et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Association between Serum Total Osteocalcin Level and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2015) C. Liu et al. HORMONE AND METABOLIC RESEARCH
- Bisphosphonates and Glucose Homeostasis: A Population-Based, Retrospective Cohort Study
- (2015) Konstantinos A. Toulis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The osteocyte plays multiple roles in bone remodeling and mineral homeostasis
- (2015) Huayue Chen et al. Medical Molecular Morphology
- Age- and sex-specific association of circulating osteocalcin with dynamic measures of glucose homeostasis
- (2015) K. Y. Jung et al. OSTEOPOROSIS INTERNATIONAL
- A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women
- (2015) Elena Passeri et al. International Journal of Endocrinology
- Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study
- (2015) Yixin Niu et al. BMC Endocrine Disorders
- The Use of Alendronate Is Associated with a Decreased Incidence of Type 2 Diabetes Mellitus—A Population-Based Cohort Study in Taiwan
- (2015) Ding-Cheng Chan et al. PLoS One
- Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs
- (2014) G. Mazziotti et al. BONE
- Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin
- (2014) Stefano Lattanzio et al. Journal of the American Heart Association
- LRP6 Enhances Glucose Metabolism by Promoting TCF7L2-Dependent Insulin Receptor Expression and IGF Receptor Stabilization in Humans
- (2013) Rajvir Singh et al. Cell Metabolism
- Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
- (2013) S. Morales-Santana et al. DIABETES CARE
- Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON-PFT, and FREEDOM trials
- (2013) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis
- (2013) Franck Oury et al. JOURNAL OF CLINICAL INVESTIGATION
- Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
- (2012) Christine Hamann et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
- (2012) Luigi Gennari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study
- (2012) B. Abrahamsen et al. OSTEOPOROSIS INTERNATIONAL
- Importance of β-Catenin in glucose and energy homeostasis
- (2012) Lynda Elghazi et al. Scientific Reports
- Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice
- (2011) Mathieu Ferron et al. BONE
- Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
- (2011) Antonia García-Martín et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study
- (2011) M. Iki et al. OSTEOPOROSIS INTERNATIONAL
- Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?
- (2010) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity
- (2008) A. Anastasilakis et al. HORMONE AND METABOLIC RESEARCH
- Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus
- (2008) Ippei Kanazawa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
- (2008) Mathieu Ferron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started